Nanjing Vazyme Biotech Co., Ltd (SHA:688105)

Nanjing Vazyme Biotech Statistics

Total Valuation

SHA:688105 has a market cap or net worth of CNY 8.35 billion. The enterprise value is 6.41 billion.

Market Cap	8.35B
Enterprise Value	6.41B

Important Dates

The last earnings date was Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688105 has 397.73 million shares outstanding. The number of shares has increased by 29.79% in one year.

Current Share Class	397.73M
Shares Outstanding	397.73M
Shares Change (YoY)	+29.79%
Shares Change (QoQ)	-37.50%
Owned by Insiders (%)	14.85%
Owned by Institutions (%)	10.11%
Float	110.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	51.20
PS Ratio	5.91
PB Ratio	2.20
P/TBV Ratio	2.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-436.02
EV / Sales	4.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.27.

Current Ratio	3.39
Quick Ratio	3.04
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -0.44% and return on invested capital (ROIC) is -1.28%.

Return on Equity (ROE)	-0.44%
Return on Assets (ROA)	-0.33%
Return on Invested Capital (ROIC)	-1.28%
Return on Capital Employed (ROCE)	-0.69%
Weighted Average Cost of Capital (WACC)	7.44%
Revenue Per Employee	493,041
Profits Per Employee	-5,127
Employee Count	2,754
Asset Turnover	0.27
Inventory Turnover	3.92

Taxes

Income Tax	-21.46M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.24% in the last 52 weeks. The beta is 0.74, so SHA:688105's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-5.24%
50-Day Moving Average	19.80
200-Day Moving Average	22.02
Relative Strength Index (RSI)	65.45
Average Volume (20 Days)	2,041,717

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688105 had revenue of CNY 1.41 billion and -14.70 million in losses. Loss per share was -0.03.

Revenue	1.41B
Gross Profit	-10.50M
Operating Income	-27.62M
Pretax Income	-38.30M
Net Income	-14.70M
EBITDA	n/a
EBIT	-27.62M
Loss Per Share	-0.03

Balance Sheet

The company has 2.94 billion in cash and 1.01 billion in debt, with a net cash position of 1.93 billion or 4.86 per share.

Cash & Cash Equivalents	2.94B
Total Debt	1.01B
Net Cash	1.93B
Net Cash Per Share	4.86
Equity (Book Value)	3.79B
Book Value Per Share	9.55
Working Capital	2.69B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	110.23M
Net Borrowing	-245.78M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is -0.74%, with operating and profit margins of -1.95% and -1.04%.

Gross Margin	-0.74%
Operating Margin	-1.95%
Pretax Margin	-2.71%
Profit Margin	-1.04%
EBITDA Margin	n/a
EBIT Margin	-1.95%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 2.38%.

Dividend Per Share	0.50
Dividend Yield	2.38%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-29.79%
Shareholder Yield	-27.34%
Earnings Yield	-0.18%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688105 has an Altman Z-Score of 5.27 and a Piotroski F-Score of 2.

Altman Z-Score	5.27
Piotroski F-Score	2